Histomorphometry of brain tumours

Neuropathology and Applied Neurobiology

Volumn 30, Issue 4, 2004, Pages 315-328

  Nafe, R ^a,b   Schlote, W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Brain tumours; Gliomas; Meningiomas; Morphometry

Indexed keywords

ANGIOGENESIS; ASTROCYTOMA; BRAIN TUMOR; CANCER GRADING; CELL NUCLEUS; CELL STRUCTURE; CHROMOSOME NOR; COMPUTER ASSISTED DIAGNOSIS; DENSITOMETRY; DNA DETERMINATION; EPENDYMOMA; EXPERIMENTAL NEOPLASM; FOURIER ANALYSIS; GLIOBLASTOMA; GLIOMA; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; MENINGIOMA; MORPHOMETRICS; NONHUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR CELL;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL NUCLEOLUS; CELL NUCLEUS; DNA, NEOPLASM; GLIOMA; HUMANS; MENINGIOMA;

EID: 4344681549     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2004.00596.x     Document Type: Review

References (103)

1. Vilanova JR, Burgos-Bretones J, Simon R, Aguirre-Urizar JM, Rivera-Pomar JM. Hypothetical evolution of necrosis in glioblastomas. Pathol Res Pract 1982; 173: 283-93
2. Schiffer D, Chio A, Giordana MT, Mauro A, Migheli A, Vigliani MC. The vascular response to tumor infiltration in malignant gliomas. Morphometric and reconstruction study. Acta Neuropathol 1989; 77: 369-78
3. Martin H, Voss K, Hufnagl P, Fröhlich K. Automated image analysis of gliomas. An objective and reproducible method for tumor grading. Acta Neuropathol (Berl) 1984; 63: 160-9
4. Stavrou D, Kaiser E, Dahme E. Zur Orthologie und Pathologie der subependymalen Glia. Karyometrische Untersuchungen bei brachyocephalen Hunden. Berl Munch Tierarztl Wochenschr 1970; 9: 164-8
5. Saini M, Bellinzona M, Meyer F, Cali G, Samii M. Morphometrical characterization of two glioma models in the brain of immunocompetent and immunodeficient rats. J Neurooncol 1999; 42: 59-67
6. Kolles H, Wangenheim A, Niedermayer I, Vince GH, Feiden W. Computer assisted grading of astrocytoma. Verh Dtsch Ges Pathol 1994; 78: 427-31
7. Martin H, Schmidt D, Heim I, Scholze K, Tanner G. Quantitative histological observations in gliomas. Zentralbl Pathol 1980; 124: 31-9
8. Soerensen FB, Braendgaard H, Christiansen AO, Bojsen-Moeller M, Reske-Nielsen E. Stereological estimates of nuclear Volume and other quantitative variables in supratentorial brain tumors. J Neurooncol 1991; 10: 253-62
9. De Benedictis G, Ricco R, Lettini T, Serio G, Penella A, Troia M, Napoli A, Delfino VP. Morphometrical investigation of medulloblastoma nuclei by S.A.M. (Shape analytical morphometry) software system. Pathol Res Pract 1992; 188: 576-80
10. Nafe R, Schlote W, Schneider B. Quantitative evaluation of nuclear pleomorphism in oligodendroglial tumors by means of Fourier-analysis of nuclear outlines. Electron J Pathol 1999; 5: 994-07.txt.
11. Nafe R, Schlote W, Schneider B. Shape analysis of tumor cell nuclei in ependymomas by means of Fourier-analysis. Anal Quant Cytol Histol 2000; 22: 475-82
12. Ricco R, Serio G, Caniglia DM, Cimmino A, Lettini T, Lozupone A, Delfino VP. Size and shape evaluation of astrocytoma nuclei with the shape analytical morphometry software system. Anal Quant Cytol Histol 1994; 16: 345-50
13. Nafe R, Schlote W. Methods for shape analysis of two-dimensional closed contours - a biologically important but widely neglected field in histopathology. Electron J Pathol 2002; 8: 022-02.txt.
14. Nafe R, Glienke W, Schlote W, Schneider B. EGFR gene-amplification in glioblastomas - is there a relationship with morphology of tumor cell nuclei and proliferative activity? Anal Quant Cytol Histol 2001; 23: 135-43
15. Kolles H, Förderer W, Bock R, Feiden W. Combined Ki-67 and Feulgen stain for morphometric determination of the Ki-67 labelling index. Histochemistry 1993; 100: 293-6
16. Nafe R, Schlote W. Topometric analysis of diffuse astrocytomas. Anal Quant Cytol Histol 2003; 25: 12-18
17. Saito A, Yoshii Y, Nose T. Image analyis of nuclear DNA content and morphometric characteristics of the tumor cells in human astrocytomas. Brain Tumor Pathol 1994; 11: 143-6
18. Coons SW, Johnson PC, Pearl DK, Olafsen AG. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human oligodendrogliomas. Neurosurgery 1994; 34: 680-7
19. Perry A, Jenkins RB, O'Fallon J, Schaefer PL, Kimmel DW, Mahoney MR, Scheithauer BW, Smith SM, Hill EM, Sebo TJ, Levitt R, Krook J, Tschetter LK, Morton RF, Buckner JC. Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. Cancer 1999; 86: 672-83
20. Ullén H, Falkmer UG, Collins VP, Auer GU. Methodologic aspects of nuclear DNA assessment of gliomas with astrocytic and/or oligodendrocytic differentiation. Anal Quant Cytol Histol 1991; 13: 168-76
21. Nafe R, Schlote W. Densitometric analysis of tumor cell nuclei in low-grade and high-grade astrocytomas. Electron J Pathol 2002; 8: 023-02.txt.
22. Björnhagen V, Lindholm J, Auer G. Analysis of nuclear DNA and morphometry and proliferating cell nuclear antigen in primary and metastatic malignant melanoma. Scand J Plast Reconstr Surg Hand Surg 1997; 31: 109-18
23. Martin H, Guski M, Guski H. Karyometric investigations of meningeomas. Zentralbl Neurochir 1984; 45: 289-98
24. Ferraraccio F, Accardo M, Cuccurullo L. Proliferative activity of ependymomas - quantitative analysis of the expression of Ki67 and AgNOR. Pathologica 1995; 87: 112-20
25. Decaestecker C, Camby I, Nagy N, Brotchi J, Kiss R, Salmon I. Improving morphology-based malignancy grading schemes in astrocytic tumors by means of computer-assisted techniques. Brain Pathol 1998; 8: 29-38
26. Scarpelli M, Montironi R, Thompson D, Bartels PH. Computer assisted analysis of medulloblastoma - a cytologic study. Anal Quant Cytol Histol 1997; 19: 387-92
27. Aronen HJ, Pardo FS, Kennedy DN, Belliveau JW, Packard SD, Hsu DW, Hochberg FH, Fischman AJ, Rosen BR. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000; 6: 2189-200
28. Schad LR, Schmitt HP, Oberwittler C, Lorenz WJ. Numerical grading of astrocytomas. Med Inform 1987; 12: 11-22
29. Salmon I, Camby I, Gras T, Rombaut K, Pasteels JL, Kiss R. The use of digital cell image analysis of Feulgen-stained nuclei to quantitatively describe morphonuclear features in a series of 174 meningeomas. Mod Pathol 1994; 7: 570-7
30. Sallinen PK, Sallinen SL, Helén PT, Rantala IS, Rautiainen E, Helin HJ, Kalimo H, Haapasalo HK. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Neuropathol Appl Neurobiol 2000; 26: 319-31
31. Nafe R, Franz K, Schlote W, Schneider B. Quantitative investigation of nuclear morphology in glioblastomas and its relation to survival time. Clin Neuropathol 2003; 22: 129-36
32. Nafe R, Schneider B. Data analysis for comparative histometry in pathology - I. Classification procedures and other statistical methods. Electron J Pathol 2000; 6: 002-3.txt.
33. Martin H, Voss K. Computerized classification of gliomas by automated microscope picture analysis (AMPA). Acta Neuropathol (Berl) 1982; 58: 261-8
34. Nafe R, Schneider B. Data Analysis for comparative histometry in pathology - II. Application of an inductive knowledge-based system for classification of gliomas based on karyometric data. Electron J Pathol 2000; 6: 002-4.txt.
35. Kolles H, Von Wangenheim A, Vince GH, Niedermayer I, Feiden W. Automated grading of astrocytomas based on histomorphometric analysis of Ki-67 and Feulgen stained paraffin sections. Classification results of neuronal networks and discriminant analysis. Anal Cell Pathol 1995; 8: 101-16
36. Klinken LH, Diemer NH, Gjerris F. Automated image analysis, histologic malignancy grading and survival in patients with astrocytic gliomas. Clin Neuropathol 1984; 3: 107-12
37. Schmitt HP, Oberwittler C, Schad LR. Computer aided classification of malignancy in astrocytomas. I. The value of nuclear parameters obtained by automated black and white image analysis. Anal Cell Pathol 1992; 4: 397-407
38. Martin H, Voss K. Automated image analysis of glioblastomas and other gliomas. Acta Neuropathol (Berl) 1982; 58: 9-16
39. Scarpelli M, Montironi R, Collan Y, Sisti S, Carletti V, Criante P, Pisani E, Papo I, Mariuzzi GM. Malignant glial tumours: prognostic value of quantitative microscopy. Neurochirurgia 1989; 32: 135-40
40. Kleihues P, Cavenee WK (eds). Pathology and Genetics of Tumors of the Nervous System. Lyon, France: IARC Press, 2000.
41. Nafe R, Schlote W, Schneider B. Planimetric characterization of tumor cell nuclei in astrocytic tumors - comparison of different tumor grades according to the WHO-classification. Electron J Pathol 2000; 6: 004-01.txt.
42. Daumas-Duport C, Varlet P, Tucker ML, Beuvon F, Cervera P, Chodkiewicz JP. Grading of astrocytomas. A simple and reproducible method. Cancer 1988; 62: 2152-65
43. Kolles H, Von-Wangenheim A, Rahmel J, Niedermayer I, Feiden W. Data-driven approaches to decision making in automated tumor grading. An example of astrocytoma grading. Anal Quant Cytol Histol 1996; 18: 298-304
44. Niedermayer I, Kolles H, Feiden W. Histologic and morphometric grading of gliomas. Anal Quant Cytol Histol 1997; 19: 301-10
45. Blankenberg FG, Teplitz RL, Ellis W, Salamat MS, Min BH, Hall L, Boothroyd DB, Johnstone IM, Enzmann DR. The influence of volume tric tumor doubling time, DNA ploidy and histologic grade on the survival of patients with intracranial astrocytomas. Am J Neuroradiol 1995; 16: 1001-12
46. Coons SW, Davis JR, Way DL. Correlations of DNA content and histology in prognosis of astrocytomas. Am J Clin Pathol 1988; 90: 289-93
47. Coons SW, Johnson PC. Regional heterogenity in the DNA content of human gliomas. Cancer 1993; 72: 3052-60
48. Spaar FW, Ahyai A, Spaar U, Gazso L, Zimmermann A. Flow-cytophotometry of nuclear DNA in biopsies of 45 human gliomas and after primary culture in vitro. Clin Neuropathol 1986; 5: 157-75
49. Yoshii Y, Saito A, Nose T. Nuclear morphometry and DNA densitometry of human gliomas by image analysis. J Neurooncol 1995; 26: 1-9
50. Yoshii Y, Saito A, Tsuboi K, Tsurushima H, Komatsu Y, Tomono Y, Hyodo A, Nose T. Nuclear characterization and G2M ploidy in human brain tumors using semiautomated image analysis. Brain Tumor Pathol 1995; 12: 61-7
51. Ferraraccio F, Accardo M. Cytometry of ependymomas using Feulgen-stained samples. Pathologica 1994; 86: 360-5
52. Reyes-Mugica M, Chou PM, Myint MM, Ridaura-Sanz C, Gonzalez-Crussi F, Tomita T. Ependymomas in children: histologic and DNA-flow cytometric study. Pediatr Pathol 1994; 14: 453-66
53. Salmon I, Kiss R, Dewitte O, Gras T, Pasteels JL, Brotchi J, Flament-Durand J. Histopathologic grading and DNA ploidy in relation to survival among 206 adult astrocytic tumor patients. Cancer 1992; 70: 538-46
54. Salmon I, Rorive S, Camby I, Decaestecker C, Pirotte B, Rombaut K, Haot J, Pasteels JL, Brotchi J, Kiss R. Stereotactic biopsies from astrocytic tumors - diagnostic information contributed by the quantitative chromatin pattern description. Anal Quant Cytol Histol 1995; 17: 332-43
55. Forsyth PA, Shaw EG, Scheithauer BW, O'Fallon JR, Layton DD, Katzmann JA. Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients. Cancer 1993; 72: 1335-42
56. Kros JM, Van Eden CG, Vissers CJ, Mulder AH, Van der Kwast TH. Prognostic relevance of DNA flow cytometry in oligodendroglioma. Cancer 1992; 69: 1791-8
57. Tomlinson FH, Scheithauer BW, Hayostek CJ, Parisi JE, Meyer FB, Shaw EG, Weiland TL, Katzmann JA, Jack CR. The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum: a clinicopathologic and flow-cytometric study. J Child Neurol 1994; 9: 301-10
58. Salmon I, Dewitte O, Remmelink M, Pastells JL, Brotchi J, Kiss R. Valeur diagnostique et prognostique de la détermination du contenu nucléaire en acid désoxyribonucléique (ADN) dans les tumeurs du système nerveux. Rev Méd Brux 1995; 16: 129-34
59. Martin H, Beil M, Hufnagl P, Wolf G, Korek G. Computer assisted image analysis of nucleolar organizer regions (NORs): a pilot study of astrocytomas and glioblastomas. Acta Histochem 1991; 90: 189-96
60. Scarpelli M, Bartels P, Montironi R, Galluzzi CM, Thompson D. Morphometrically assisted grading of astrocytomas. Anal Quant Cytol Histol 1994; 16: 351-6
61. Tokiyoshi K, Yoshimine T, Maruno M, Nakagawa H, Iwata Y, Kuroda R, Hayakawa T. The analysis of nucleolar organizer regions of astrocytomas with various histologic malignancies. No To Shinkei 1992; 44: 1083-6
62. Haberland C, Martin H, Guski H, Hufnagl P, Vogel S. AgNOR analysis of astrocytomas in childhood. Zentralbl Neurochir 1996; 57: 5-11
63. Robertson AJ, Anderson JM, Brown RA, Slidders W, Beck JS. Grading of astrocytomas using a quantimet 720 image-analysing computer. J Clin Pathol 1978; 31: 469-74
64. Camby I, Belot N, Rorive S, Lefranc F, Maurage CA, Lahm H, Kaltner H, Hadari Y, Ruchoux M, Brotchi J, Zick Y, Salmon I, Gabius HJ, Kiss R. Galactins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas and significantly modulate tumor astrocyte migration. Brain Pathol 2001; 11: 12-26
65. Kip1/retinoblastoma protein expression. Virchows Arch 2001; 439: 547-51
66. Kösel S, Scheithauer BW, Graeber MB. Genotype-phenotype correlation in gemistocytic astrocytomas. Neurosurgery 2001; 48: 187-94
67. Wesseling P, van der Laak JA, de Leeuw H, Ruiter DJ, Burger PC. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg 1994; 81: 902-9
68. Wesseling P, van der Laak JA, Link M, Teepen HL, Ruiter DJ. Quantitative analysis of microvascular changes in diffuse astrocytic neoplasms with increasing grade of malignancy. Hum Pathol 1998; 29: 352-8
69. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic factor for patients with astroglial tumors. Cancer 1996; 77: 362-72
70. Korkolopoulou P, Patsouris E, Kavantzas N, Konstantinidou AE, Christodoulou P, Thomas-Tsagli E, Pananikolaou A, Eftychiadis C, Pavlopoulos PM, Angelidakis D, Rologis D, Davaris P. Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms. Neuropathol Appl Neurobiol 2002; 28: 57-66
71. Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W. Triple approach for diagnosis and grading of meningeomas: histology, morphometry of Ki-67/Feulgen-stainings and cytogenetics. Acta Neurochir 1995; 137: 174-81
72. Plate KH, Rüschoff J, Mennel HD. Nucleolar organizer regions in meningeomas - correlation with histopathologic malignancy grading, DNA cytometry and clinical outcome. Anal Quant Cytol Histol 1990; 12: 429-38
73. Jääskeläinen J, Louis DN, Paulus W, Haltia MJ. Haemangiopericytoma. In Pathology and Genetics of Tumors of the Nervous System. Eds P Kleihues, WK Cavenee. Lyon. France: IARC Press, 2000; 190-2
74. Penella A, Ferri C, Lettini T, Serio G, Cimmino A, Caniglia DM, Giangaspero F, Ricco R. Atypical meningioma: a morphometric analysis of nuclear pleomorphism. Pathologica 2000; 92: 25-31
75. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading - an analysis of histologic parameters. Am J Surg Pathol 1997; 21: 1455-65
76. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. Malignancy in meningeomas - a clinicopathologic study of 116 patients with grading implications. Cancer 1999; 85: 2046-56
77. Christensen D, Laursen H, Klinken L. Prediction of recurrence in meningeomas after surgical treatment - a quantitative approach. Acta Neuropathol (Berl) 1983; 61: 130-4
78. Serio G, Caniglia A, Ferri C, Caniglia DM, Lettini T, Carlucci M, D'Aprile M, Cimmino A, Serio R, Ricco R. Recurring intracranial meningiomas. Morphometrical evaluation of nuclear pleomorphism by S.A.M. (shape analytical morphometry) system. Boll Soc Ital Biol Sper 1996; 72: 147-53
79. Barz H, Voss K, Kunze KD. Karyometric studies on a case of recurrent and metastasizing meningeoma. Zentralbl Allg Pathol 1982; 126: 261-7
80. Dangou JM, Salmon I, Torres LFB, Budel V, Ndiaye PD, Pasteels JL, Verhest A, Kiss R. DNA histogram typing in retinoblastomas and neuroblastomas. Mod Pathol 1993; 6: 408-13
81. McManamy CS, Lamont JM, Taylor RE, Cole M, Pearson ADJ, Clifford SC, Ellison DW. Morphophenotypic variation predicts clinical behaviour in childhood non-desmoplastic medulloblastomas. J Neuropathol Exp Neurol 2003; 62: 627-32
82. Huber H, Eggert A, Janss AJ, Wiewrodt R, Zhao H, Sutton LN, Rorke LB, Phillips PC, Grotzer MA. Angiogenic profile of childhood primitive neuroectodermal brain tumours/medulloblastomas. Eur J Cancer 2001; 37: 2064-72
83. Galatioto S, Marafioto T, Cavallari V, Batolo D. Glioma-tosis cerebri - clinical, neuropathological, immunohistological and morphometric studies. Zentralbl Pathol 1993; 139: 261-7
84. Ko LW, Koestner A. Morphologic and morphometric analyses of butyrate-induced alterations of rat glioma cells in vitro. J Natl Cancer Inst 1980; 65: 1017-27
85. Krajewski S, Kiwit JC, Wechsler W. RG2 glioma growth in rat cerebellum after subdural implantation. J Neurosurg 1986; 65: 222-9
86. Hurwitz LS, Rubinstein LJ. Tetrazolium salt reduction studies in slide histochemistry. II. A quantitative study in two experimental tumor models. Enzymologia 1969; 37: 21-32
87. Rubinstein LJ, Hurwitz LS. Tetrazolium salt reduction studies in slide histochemistry. I. Observations on the reductase activity of experimental tumours implanted in the mouse brain and liver as measured by optical densitometry. Enzymologia 1969; 37: 1-20
88. Luthert PJ, Lantos PL. A morphometric study of the microvasculature of a rat glioma. Neuropathol Appl Neurobiol 1985; 11: 461-73
89. Rucklidge GJ, Dean V, Robins SP, Mella O, Bjerkvig R. Immunolocalization of extracellular matrix proteins during brain tumor invasion in BD IX rats. Cancer Res 1989; 49: 5419-23
90. Seitz RJ, Deckert M, Wechsler W. Vascularization of syngenic intracerebral RG2 and F98 rat transplantation tumors. Acta Neuropathol 1988; 76: 599-605
91. Stan W, Nemanti MN, Pietsch T, Walter GF, Dietz H. In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor. J Neurosurg 1995; 82: 1044-52
92. Van der Sanden BPJ, Zandt HJA, Hoofd L, De Graaf RA, Nicolay K, Rijken PFJW, Van der Kogel AJ, Heerschap A. Global HDO uptake in human glioma xenografts is related to the perfused capillary distribution. Magnetic Res Med 1999; 42: 479-89
93. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ. Meningiomas. In Pathology and Genetics of Tumors of the Nervous System. Eds P Kleihues, WK Cavenee. Lyon. France: IARC Press, 2000; 176-84
94. Prayson RA. Cell proliferation and tumors of the central nervous system. Part II: radiolabelling, cytometric, and immunohistochemical techniques. J Neuropathol Exp Neurol 2002; 61: 663-72
95. Ringertz J. Grading of gliomas. Acta Pathol Microbiol Scand 1950; 27: 51-64
96. Coons SW, Johnson PC, Scheithauer BW, Yates AJ, Pearl DK. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer 1997; 79: 1381-93
97. Prayson RA, Agamanolis DP, Cohen ML, Estes ML, Kleinschmidt-DeMasters BK, Abdul-Karim F, McClure SP, Sebek BA, Vinay R. Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci 2000; 175: 33-9
98. Scarpelli M, Montironi R, Ansuini G, Pisani E, Rychlicki F, Papo I, Mariuzzi GM. The value of morphometry in prediction of survival in oligodendrogliomas. Clin Neuropathol 1987; 6: 155-9
99. Scarpelli M, Montironi R, Thompson D, Bartels P. Computer-assisted discrimination of glioblastomas. Anal Quant Cytol Histol 1997; 19: 369-75
100. Weibel ER. Stereological Methods, Vol. 1. London-New York-Toronto-Sydney- San Francisco: Academic Press, 1979
101. O'Callaghan JF. An alternative definition for 'neighborhood of a point'. IEEE Trans Comput 1975; 24: 1121-5
102. Kayser K. Syntactic structural analyses in histopathology. In Morphometry in Cyto-and Histopathology. Eds G Burger, M Oberholzer, W Gössner. Berlin-Heidelberg-New York: Springer, 1988; 164-78
103. Zülch KJ. Histological typing of tumours of the central nervous system. International Histological Classification of Tumours, No. 21. Geneva: WHO, 1979